Intimation of Earnings Conference Call for investors and analysts on Tuesday, January 23, 2024 at 04:00 P.M. IST Revised intimation is only due to some technical error in the link and all other inform...

January 16, 2024

DCS-CRD BSE Limited First Floor, New Trade Wing Rotunda Building, Phiroze Jeejeebhoy Towers Dalal Street, Fort, Mumbai 400001 Fax No.2272 3121/2037/2039

Listing Compliance National Stock Exchange of India Ltd. Exchange Plaza, 5th Floor, Plot No. C/1, ‘G’ Block, Bandra- Kurla Complex Bandra East, Mumbai 400 051 Fax No.2659 8237/8238

Stock Code: 543213

Stock Code: ROSSARI

Dear Sir/Madam,

Sub.: Revised Intimation of Earnings Conference Call for investors and analysts for Q3 FY24

Ref.: Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations,

2015

Pursuant to the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby intimate that an Earnings Conference Call for investors and analysts is being organized by the Company on Tuesday, January 23, 2024 at 04:00 P.M. IST.

The conference call will be initiated with a brief management discussion on the results for quarter and nine months ended December 31, 2023 followed by an interactive Question & Answer session.

Invite in this regard is enclosed for your information and record.

We would further like to submit that revised intimation is only due to some technical error in the link and all other information of the Earnings Conference Call shall remain unchanged.

The same may please be taken on record and suitably disseminated to all concerned.

Thanking you,

Yours Sincerely, For Rossari Biotech Limited

Digitally signed by PARUL GUPTA Date: 2024.01.16 15:12:16 +05'30'

PARUL GUPTA _______________________ Parul Gupta Company Secretary & Compliance Officer Membership No.: A38895

Encl.: as above

Rossari Biotech Limited Q3 FY24 Earnings Conference Call

Tuesday, January 23, 2024, at 4:00 p.m. IST

Rossari Biotech Limited (Rossari) will host a conference call for investors and analysts on Tuesday, January 23, 2024, at 4:00 pm IST.

The conference call will be initiated with a brief management discussion on the Q3 FY24 results, to be declared on Saturday, January 20, 2024, followed by an interactive Question & Answer session.

Senior Management team of the Company will be present to address the call.

Dial-in details are as follows:

Timing

Universal dial-in

4:00 p.m. IST on Tuesday, January 23, 2023

+ 91 22 6280 1141 / 7115 8042

To enable participants to connect to the conference call without having to wait for an operator, please register at the below mentioned link:

Pre-registration (Zero wait time to join the call)

Page | 1

About Rossari:

Rossari Biotech Limited (Rossari) (BSE: 543213, NSE: ROSSARI), is a Speciality-Chemicals manufacturer

providing intelligent and sustainable solutions for customers across industries. Headquartered at

Mumbai, India, the Company operates strategically located manufacturing facilities at Silvassa and

Dahej. The Company offers tailor-made solutions for Home, Personal Care and Performance chemicals

(HPPC), Textile speciality chemicals and Animal Health and Nutrition (AHN). With differentiated

product offerings, Rossari caters to an array of applications across FMCG, Home care, Industrial

Cleaning, Personal Care, Textile Speciality Chemicals, Performance Chemicals, the Animal Health and

Nutrition and Pet Care businesses. The Company has an extensive and a dedicated network of

distributors spread all over India.

For more information, please visit www.rossari.com OR contact:

Ketan Sablok Rossari Biotech Limited Tel: +91 22 6123 3800 Email: ketan.sablok@rossari.com

Anoop Poojari / Mitesh Jain CDR India Tel: +91 98330 90434 / 96194 44691 Email: anoop@cdr-india.com mitesh@cdr-india.com

DISCLAIMER:

Certain statements that may be made or discussed at the conference call may be forward-looking

statements. Such forward-looking statements are subject to certain risks and uncertainties like

significant changes in economic environment in India and overseas, tax laws, import duties, litigation,

labour relations etc. Actual results might differ substantially from those expressed or implied. Rossari

Biotech Ltd will not be in any way responsible for any action taken based on such statements and

discussions; and undertakes no obligation to publicly update these forward-looking statements to reflect

subsequent events or circumstances.

Page | 2